Characterization of clinical features and outcome for human-to-human transmitted severe fever with thrombocytopenia syndrome

Infectious Diseases

Volumn 50, Issue 8, 2018, Pages 601-608

  Jia, Bei ^a   Wu, Weihua ^a   Huang, Rui ^a   Wang, Guiyang ^a   Song, Peixin ^a   Li, Yang ^a   Liu, Yong ^a   Xiong, Yali ^a   Yan, Xiaomin ^a   Hao, Yingying ^a   Xia, Juan ^a   Zhang, Zhaoping ^a   Chen, Yuxin ^a   Wu, Chao ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Clinical features; Emerging infectious disease; Human to human transmission; Prognosis; Severe fever with thrombocytopenia syndrome

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; IMMUNOGLOBULIN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT THROMBOPOIETIN; RIBAVIRIN; STEROID;

ADULT; AGED; ARTICLE; CASE FATALITY RATE; CLINICAL FEATURE; CLINICAL OUTCOME; COHORT ANALYSIS; CONTROLLED STUDY; CRYOPRECIPITATION; DISEASE COURSE; DISEASE SEVERITY; DISEASE TRANSMISSION; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; NEUROLOGIC DISEASE; NORMAL VALUE; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME; SURVIVAL RATE; TERTIARY CARE CENTER; VIRUS LOAD; BUNYAVIRUS INFECTION; CHINA; COMPLICATION; CONTACT EXAMINATION; FEVER; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PHLEBOVIRUS; PHYSIOLOGY; THROMBOCYTOPENIA; TRANSMISSION; VIROLOGY;

ADULT; AGED; BUNYAVIRIDAE INFECTIONS; CHINA; CONTACT TRACING; FEMALE; FEVER; HUMANS; MALE; MIDDLE AGED; PHLEBOVIRUS; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS; THROMBOCYTOPENIA; VIRAL LOAD;

EID: 85044076932     PISSN: 23744235     EISSN: None     Source Type: Journal    
DOI: 10.1080/23744235.2018.1449962     Document Type: Article

References (23)

1. Yu XJ, Liang MF, Zhang SY, et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med. 2011;364:1523–1532.
2. Shin J, Kwon D, Youn SK, et al. Characteristics and factors associated with death among patients hospitalized for severe fever with thrombocytopenia syndrome, South Korea, 2013. Emerg Infect Dis. 2015;21:1704–1710.
3. Kato H, Yamagishi T, Shimada T, et al. Epidemiological and clinical features of severe fever with thrombocytopenia syndrome in Japan, 2013–2014. PLoS One. 2016;11:e0165207.
4. McMullan LK, Folk SM, Kelly AJ, et al. A new phlebovirus associated with severe febrile illness in Missouri. N Engl J Med. 2012;367:834–841.
5. Liu K, Zhou H, Sun RX, et al. A national assessment of the epidemiology of severe fever with thrombocytopenia syndrome, China. Sci Rep. 2015;5:9679.
6. Lyu Y, Ding F, Sun J, et al. Seroprevalence and risk factors of severe fever with thrombocytopenia syndrome virus infection in endemic areas. Infect Dis (Lond). 2016;48:544–549.
7. Bao CJ, Qi X, Wang H., A novel bunyavirus in China. N Engl J Med. 2011;365:862–863. author reply 864–865.
8. Choi SJ, Park SW, Bae IG, et al. Severe fever with thrombocytopenia syndrome in South Korea, 2013–2015. PLoS Negl Trop Dis. 2016;10:e0005264.
9. Bao CJ, Guo XL, Qi X, et al. A family cluster of infections by a newly recognized bunyavirus in Eastern China, 2007: further evidence of person-to-person transmission. Clin Infect Dis. 2011;53:1208–1214.
10. Tang X, Wu W, Wang H, et al. Human-to-human transmission of severe fever with thrombocytopenia syndrome bunyavirus through contact with infectious blood. J Infect Dis. 2013;207:736–739.
11. Chen Y, Jia B, Huang R, et al. Occupational severe fever with thrombocytopenia syndrome following needle-stick injury. Infect Control Hosp Epidemiol. 2017;38:760–762.
12. Ding S, Niu G, Xu X, et al. Age is a critical risk factor for severe fever with thrombocytopenia syndrome. PLoS One. 2014;9:e111736
13. Cui N, Bao XL, Yang ZD, et al. Clinical progression and predictors of death in patients with severe fever with thrombocytopenia syndrome in China. J Clin Virol. 2014;59:12–17.
14. Chen Y, Jia B, Liu Y, et al. Risk factors associated with fatality of severe fever with thrombocytopenia syndrome: a meta-analysis. Oncotarget. 2017;8:89119–89129.
15. Jia B, Yan X, Chen Y, et al. A scoring model for predicting prognosis of patients with severe fever with thrombocytopenia syndrome. PLoS Negl Trop Dis. 2017;11:e0005909.
16. Li J, Han Y, Xing Y, et al. Concurrent measurement of dynamic changes in viral load, serum enzymes, T cell subsets, and cytokines in patients with severe fever with thrombocytopenia syndrome. PLoS One. 2014;9:e91679.
17. Zhang YZ, He YW, Dai YA, et al. Hemorrhagic fever caused by a novel bunyavirus in China: pathogenesis and correlates of fatal outcome. Clin Infect Dis. 2012;54:527–533.
18. Zhang W, Li M, Xiong S, et al. Decreased myeloid dendritic cells indicate a poor prognosis in patients with severe fever with thrombocytopenia syndrome. Int J Infect Dis. 2017;54:113–120.
19. Gai Z, Liang M, Zhang Y, et al. Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact. Clin Infect Dis. 2012;54:249–252.
20. Wang Y, Deng B, Zhang J, et al. Person-to-person asymptomatic infection of severe fever with thrombocytopenia syndrome virus through blood contact. Intern Med. 2014;53:903–906.
21. Chen H, Hu K, Zou J, et al. A cluster of cases of human-to-human transmission caused by severe fever with thrombocytopenia syndrome bunyavirus. Int J Infect Dis. 2013;17:e206–e208.
22. Martinez VP, Bellomo C, San Juan J, et al. Person-to-person transmission of Andes virus. Emerging Infect Dis. 2005;11:1848–1853.
23. Martinez-Valdebenito C, Calvo M, Vial C, et al. Person-to-person household and nosocomial transmission of Andes hantavirus, Southern Chile, 2011. Emerg Infect Dis. 2014;20:1629–1636.